Living Diabetes is an evidence-based diabetes resource. Our editorial team curates clinical content from NICE, NHS, ADA and Diabetes UK guidelines to help readers understand and live well with diabetes.
Recent case reports have raised a rare but serious safety question involving semaglutide, poor intake, rapid weight loss, thiamine deficiency, and neurological symptoms. The evidence shows an association, not proven causation.
The FDA approved monthly Tryngolza for adults with severe hypertriglyceridemia. Here is what people with diabetes should know about its purpose, pancreatitis risk and safety.
A Lancet Diabetes & Endocrinology consensus statement highlights nutrition, muscle, function, GI symptoms, and psychological support during incretin therapy.
Is 10,000 steps the right goal for managing diabetes? Learn how to personalize your walking routine, manage blood glucose, and stay safe with medication…
